Cargando…

Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards

BACKGROUND: Up to 83% of patients with SLE stop taking hydroxychloroquine (HCQ) within the first year due to knowledge gaps regarding the survival benefits of HCQ versus inflated fears of rare toxicity. Thus, there is a need for a shared decision-making tool that highlights HCQ’s significant benefit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garg, Shivani, Ferguson, Sancia, Chewning, Betty, Gomez, Shelby, Keevil, Jon, Bartels, Christie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Epidemiology and Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387621/ https://www.ncbi.nlm.nih.gov/pubmed/37500292 http://dx.doi.org/10.1136/lupus-2023-000935

Ejemplares similares

Hydroxychloroquine (HCQ): real treatment or false hope?
por: El Bakkouri, Karim
Publicado: (2021)

Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues
por: Mohanta, Tapan Kumar, et al.
Publicado: (2020)

Quantitative Fundus Autofluorescence in HCQ Retinopathy
por: Greenstein, Vivienne C., et al.
Publicado: (2020)

Pharmacist's perspective on HCQ treatment of COVID‐19
por: Wang, Ya‐Ling, et al.
Publicado: (2020)

HCQ induced QT prolongation- Primum non nocere
por: Mahendran, A.J., et al.
Publicado: (2020)

Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

HCQ use not protective against SARS-CoV-2
por: Onuora, Sarah
Publicado: (2020)

The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 –a systematic review and meta-analysis
por: Choudhuri, Anirban Hom, et al.
Publicado: (2021)

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy
por: Krueger, Janna, et al.
Publicado: (2021)

The ‘myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19’ is far from reality
por: Dhibar, Deba Prasad, et al.
Publicado: (2023)

A Study on Hydroxychloroquine (HCQ) as prophylaxis among Health care worker (HCW) for SARS -Co V-2 infection
por: Ghosh, Anindya, et al.
Publicado: (2021)

Long Term Pharmacological Perturbation of Autophagy in Mice: Are HCQ Injections a Relevant Choice?
por: Masson, Jean-Daniel, et al.
Publicado: (2020)

HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers
por: Jha, Sujeet, et al.
Publicado: (2021)

MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition
por: Silvis, Mark R., et al.
Publicado: (2023)

Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design
por: Sinha, Meetali, et al.
Publicado: (2021)

Effect of quantitative real-time RT-PCR reaction sensitivity in determining the efficacy of HCQ prophylaxis for COVID-19
por: Gouda, Divakara, et al.
Publicado: (2020)

Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)
por: Naggie, Susanna, et al.
Publicado: (2023)

Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention development
por: Garg, Shivani, et al.
Publicado: (2022)

Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection
por: Boretti, Alberto
Publicado: (2022)

Structural basis of anti-SARS-CoV-2 activity of HCQ: specific binding to N protein to disrupt its interaction with nucleic acids and LLPS
por: Dang, Mei, et al.
Publicado: (2021)

LB-17. Efficacy of Hydroxychloroquine (HCQ) for Post-exposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Blinded, Randomized, Controlled Trial
por: Brown, Elizabeth R, et al.
Publicado: (2020)

Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis
por: Chen, Ming-Yao, et al.
Publicado: (2021)

Correction: Chen et al. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers 2021, 13, 3227
por: Chen, Ming-Yao, et al.
Publicado: (2023)

Rheumatologists’ perspective on hydroxychloroquine guidelines
por: Winebrake, James, et al.
Publicado: (2020)

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2011)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
por: Osmani, Zgjim, et al.
Publicado: (2021)

Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety
por: Cornet, Alain, et al.
Publicado: (2021)

Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine
por: Almeida-Brasil, Celline C, et al.
Publicado: (2022)

Can “Googling” correct misbelief? Cognitive and affective consequences of online search
por: Kobayashi, Tetsuro, et al.
Publicado: (2021)

Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus
por: Vázquez-Otero, Ileana, et al.
Publicado: (2020)

Real-life daily activity: the impact of misbeliefs on quality of life among cancer patients
por: Shachar, E., et al.
Publicado: (2022)

Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19
por: Rosenberg, Eli S., et al.
Publicado: (2020)

Intentions to use a novel Zika vaccine: the effects of misbeliefs about the MMR vaccine and perceptions about Zika
por: Ophir, Yotam, et al.
Publicado: (2018)

Quality-of-Life Outcomes With Minimally Invasive Transforaminal Lumbar Interbody Fusion Based on Long-Term Analysis of 304 Consecutive Patients
por: Perez-Cruet, Mick J., et al.
Publicado: (2014)

Treatment Outcome of Metastatic Spine Tumor in Lung Cancer Patients: Did the Treatments Improve Their Outcomes?
por: Uei, Hiroshi, et al.
Publicado: (2017)

Prognostic predictors of early mortality from exsanguination in adult trauma: a Malaysian trauma center experience
por: Huei, Tan Jih, et al.
Publicado: (2017)

What is the patient experience of surgical care during the coronavirus disease 2019 (COVID-19) pandemic? A mixed-methods study at a single institution
por: Shannon, Adrienne B., et al.
Publicado: (2021)

Reduced duration of stay after elective colorectal surgery during the peak phase of COVID-19 pandemic: A positive effect of infection risk awareness?
por: Spinelli, Antonino, et al.
Publicado: (2021)

Longitudinal electrocardiographic assessment in Brugada syndrome
por: Daw, Jonathan M., et al.
Publicado: (2022)

Measuring cataract outcomes
por: Buchan, John
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vg16d87bhjjdj6hgj89ci40vo3